WFH’s letter of support for the EnzySystem project

We are proud to share that we have received a letter of support from the World Federation of Hemophilia (WFH), acknowledging the potential of our EnzySystem to improve how inherited bleeding disorders are diagnosed and managed.

Improving diagnosis is a core priority for the WFH, with a goal to increase the number of people diagnosed with hemophilia and von Willebrand disease by 25% between 2021 and 2025. Achieving this requires better awareness, local capacity building, and access to point-of-care diagnostic tools, especially in resource-limited areas. We share these values and we highly appreciate this support! 

📜 WFH letter of support